Sharon Winborn is 3 Years Old. She was diagnosed with Nephroblastoma at the age of 9 months old. At just 11 months old, she underwent surgery to remove the left kidney. After a period of remission, another tumor was discovered in the same cavity. After surgery, she received Radiotherapy and Chemotherapy. She kindly asks for any support possible to help the struggling parents to pay for the special treatments. Sharon wants to have a normal healthy life and hopes for a healthy future.
” What is neuroblastoma?
Neuroblastoma is a childhood cancer that starts in immature nerve cells (neuroblasts). The term “neuro” refers to nerves, and “blastoma” refers to a tumor of immature or developing cells.
- Neuroblastoma tumors can occur anywhere in the body, but about 65% of them occur in the abdomen
- Neuroblastoma tumors are unique. Some may go away on their own without treatment, while others may spread (metastasize) throughout the body”
“Treatment for non–high-risk (low- or intermediate-risk) neuroblastoma
Children with non–high-risk neuroblastoma have a low– or intermediate-risk classification. They make up about half of the newly diagnosed cases each year. This group has excellent event-free and overall survival with current therapy in clinical trials. Children with non–high-risk neuroblastoma generally have better treatment outcomes than those with high-risk neuroblastoma. Learn about the differences between non–high-risk and high-risk neuroblastoma classifications.
Recently, the goal for treatment of non–high-risk neuroblastoma has been to reduce the intensity of therapy to minimize short- and long-term side effects while continuing to maintain excellent outcomes.”
“The intensity of neuroblastoma treatment will vary depending on the risk group assigned to your child’s disease. If your child has high-risk neuroblastoma, you can find information about their treatment in this section. To learn about risk groups overall, you can find information on the Understanding the Treatment Options page.
The treatment goal for children with high-risk neuroblastoma is to prevent neuroblastoma from coming back (relapse). Survival rates are poor for high-risk neuroblastoma patients after relapse, and that’s why the treatment for high-risk neuroblastoma uses multiple intensive therapies.”
Multiple therapies are used to treat high-risk neuroblastoma
High-risk neuroblastoma can be aggressive and difficult to treat. It will require intensive treatment with multiple types of therapy. This approach has significantly improved survival rates, and research is now focused on new treatments to further improve survival rates.
The standard treatment regimen for high-risk neuroblastoma at most hospitals is broken into 3 phases and lasts about 18 months.